KR20210116851A - A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell - Google Patents

A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell Download PDF

Info

Publication number
KR20210116851A
KR20210116851A KR1020200032929A KR20200032929A KR20210116851A KR 20210116851 A KR20210116851 A KR 20210116851A KR 1020200032929 A KR1020200032929 A KR 1020200032929A KR 20200032929 A KR20200032929 A KR 20200032929A KR 20210116851 A KR20210116851 A KR 20210116851A
Authority
KR
South Korea
Prior art keywords
stem cell
membrane
cells
cell extract
induced
Prior art date
Application number
KR1020200032929A
Other languages
Korean (ko)
Other versions
KR102419735B1 (en
Inventor
김영실
Original Assignee
주식회사 티스템
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 티스템 filed Critical 주식회사 티스템
Priority to KR1020200032929A priority Critical patent/KR102419735B1/en
Publication of KR20210116851A publication Critical patent/KR20210116851A/en
Application granted granted Critical
Publication of KR102419735B1 publication Critical patent/KR102419735B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition for treating anti-inflammation induced by hydrogen peroxide of a membrane-free stem cell extract. The configuration thereof is characterized by using an adipose stem cell-derived membrane-free stem cell extract at a concentration of 0.5 μg/mL. The present invention has a protective effect on oxidative stress due to H_2O_2 in HPLF cells of human adipose tissue-derived membrane-free stem cell extract, and when treating the membrane-free stem cell extract to HPLF cells induced by oxidative damage with H_2O_2, cell viability increases, thereby having an effect of protecting cells from oxidative stress.

Description

무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물{A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell}Composition for the treatment of anti-inflammatory induced by hydrogen peroxide of amacrine stem cell extract {A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell}

본 발명은 항염증 치료용 조성물에 관한 것으로, 더욱 상세하게는 지방세포에서 분리된 줄기세포에서 추출된 물질을 과산화수소의 스트레스 등으로 인하여 발생되는 염증을 치료할 수 있는 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물에 관한 것이다. The present invention relates to a composition for anti-inflammatory treatment, and more particularly, a substance extracted from stem cells isolated from adipocytes is induced by hydrogen peroxide of amacrine stem cell extract, which can treat inflammation caused by stress of hydrogen peroxide, etc. It relates to a composition for the treatment of anti-inflammatory drugs.

치주염은 가장 흔히 발생하는 대표적인 구강질환으로, 치주인대, 치은 등을 파괴하며, 심각할 경우 치아 손실의 원인이 된다. 이러한 치주 염증의 발생은 염증성 세균으로 인한 산화적 스트레스가 주요 원인으로 알려져 있다. H2O2는 생체 대사과정 중 발생하는 중간 대사산물 중의 하나이지만, 과다 생성 시 세포에 산화적 스트레스를 유발하는 대표적인 물질 중의 하나이다. Periodontitis is the most common oral disease and destroys periodontal ligaments and gingiva, and in severe cases causes tooth loss. It is known that oxidative stress caused by inflammatory bacteria is the main cause of the occurrence of such periodontal inflammation. H2O2 is one of the intermediate metabolites generated during biological metabolism, but is one of the representative substances that induce oxidative stress in cells when excessively produced.

H2O2로 인한 산화적 스트레스는 치주질환의 발병에 중요한 역할을 하며, 특히 사람의 치주인대 섬유모세포(HPLF: Human Periodontal Ligament Fibroblasts, 이하 HPLF)에서 염증성 cytokines 및 chemokines 등의 염증 인자를 방출하여 염증반응, 세포 형태의 파괴 및 세포사멸을 일으켜 치주염을 일으키는 것으로 알려져 있다. Oxidative stress caused by H2O2 plays an important role in the pathogenesis of periodontal disease, and in particular, human periodontal ligament fibroblasts (HPLFs) release inflammatory factors such as inflammatory cytokines and chemokines to induce inflammatory responses, It is known to cause periodontitis by causing cell morphology and cell death.

따라서 염증 반응 개선을 통한 치주염 치료 연구가 활발히 이루어지고 있으며, 본 연구에서는 줄기세포(stem cell)를 이용하여 치주염 개선 가능성을 확인하고자 한다.Therefore, research on the treatment of periodontitis by improving the inflammatory response is being actively conducted.

인체의 장기, 피부, 뼈, 연골 등을 구성하는 세포들은 세포사멸과 세포생성을 통해 체내 항상성을 유지하는데, 세포 생성을 새롭게 유도하는 세포를 줄기세포라고 한다.Cells that make up organs, skin, bones, and cartilage of the human body maintain homeostasis in the body through apoptosis and cell production. Cells that newly induce cell production are called stem cells.

줄기세포의 일종인 성체줄기세포(adult stem cell)는 주로 재생기능이 우수하며, 자가복제력이 매우 뛰어난 것으로 알려져 있다. 또한, 성체줄기세포는 다른 조직으로 다중 분화될 수 있는 능력을 가지며, 조직의 손상시 정상적인 복구와 회복에 도움을 줄 뿐만 아니라 항염증 작용이 동반되는 것으로 보고되었다. 따라서 성체줄기세포를 이용하여 치매, 심장병, 당뇨병, 피부개선 등 다양한 질환에서의 치료에 활발히 이용되어지고 있다.Adult stem cells (adult stem cells), a type of stem cells, are known to have excellent regenerative function and excellent self-renewal ability. In addition, it has been reported that adult stem cells have the ability to be multi-differentiated into other tissues, and not only help normal repair and recovery when tissue is damaged, but also have anti-inflammatory action. Therefore, adult stem cells are being actively used to treat various diseases such as dementia, heart disease, diabetes, and skin improvement.

특허등록 제 10-2082745호Patent Registration No. 10-2082745

본 발명의 목적은 무막줄기세포를 이용하여 H2O2 유도 산화적 손상에 대한 치주염 보호 효과를 확인하여 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물을 제공하는 것이다. It is an object of the present invention to provide a composition for treating anti-inflammatory drugs induced by hydrogen peroxide of amacrine stem cell extracts by confirming the periodontitis protective effect against H2O2-induced oxidative damage using amacrine stem cells.

상술한 목적을 달성하기 위한 것으로, 본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물은, 지방줄기세포에서 유래된 무막줄기세포의 추출물을 0.5μg/mL의 농도로 사용하는 것을 특징으로 한다. In order to achieve the above object, the composition for anti-inflammatory treatment induced by hydrogen peroxide of the adipose stem cell extract of the present invention uses an adipose stem cell-derived amacrine stem cell extract at a concentration of 0.5 μg/mL. characterized.

상기 무막줄기세포는, 지방조직에서 지방줄기세포를 분리하여 정제한 후, 37℃에서, 5%의 CO2 조건의 인큐베이터(incubator)에서 초기배양 후, 계대배양을 6 내지 10회 반복하고, 배지를 제거한 후, 줄기세포의 세포막을 제거한 후 추출물을 획득하는 것을 특징으로 한다. After the adipose stem cells are separated and purified from adipose tissue, the adipose stem cells are initially cultured in an incubator under a condition of 5% CO2 at 37°C, and subculture is repeated 6 to 10 times, and the medium is After removal, it is characterized in that the extract is obtained after removing the cell membrane of the stem cells.

본 발명에 의한 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물에서는 다음과 같은 효과가 있다. The composition for anti-inflammatory treatment induced by hydrogen peroxide of the amacrine stem cell extract according to the present invention has the following effects.

사람의 지방조직 유래 무막줄기세포추출물의 HPLF 세포에서 H2O2로 인한 산화적 스트레스 보호 효과가 있으며, H2O2로 산화적 손상을 유도한 HPLF 세포에 무막줄기세포추출물 처리 시, 세포 생존율이 증가함을 통해, 산화적 스트레스로부터 세포를 보호하는 효과가 있다.H2O2 induced oxidative stress protection effect in HPLF cells derived from human adipose tissue, and cell viability increases when treating HPLF cells inducing oxidative damage with H2O2. It has the effect of protecting cells from oxidative stress.

도 1은 본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물을 농도별로 적용한 경우에 대한 세포생존율을 보인 그래프.
도 2는 본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물을 농도별로 적용한 경우에 대한 염증 관련 인자인 NF-κB, iNOS 및 IL-6 단백질 발현을 측정한 것을 나타낸 그래프.
도 3은 본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물을 농도별로 적용한 경우에 대한 세포사멸 보호 작용 기전을 확인하기 위해, caspase-9, -3, PARP 단백질 발현을 측정한 결과를 나타낸 그래프.
1 is a graph showing the cell viability when the composition for the treatment of anti-inflammatory induced by hydrogen peroxide of the present invention amacrine stem cell extract is applied by concentration.
Figure 2 is a graph showing the measurement of the expression of NF-κB, iNOS and IL-6 proteins, which are inflammation-related factors, when the composition for treating anti-inflammatory drugs induced by hydrogen peroxide of the present invention amacrine stem cell extract is applied by concentration.
Figure 3 is to confirm the apoptosis protection mechanism for the case of applying the composition for the treatment of anti-inflammatory induced by hydrogen peroxide of the present invention of the present invention by concentration, caspase-9, -3, PARP protein expression was measured. A graph showing the results.

이하, 본 발명에 의한 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물의 바람직한 실시예가 첨부된 도면을 참고하여 상세하게 설명한다. Hereinafter, a preferred embodiment of the composition for treating anti-inflammatory induced by hydrogen peroxide of the amacrine stem cell extract according to the present invention will be described in detail with reference to the accompanying drawings.

본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물은, 지방줄기세포에서 유래된 무막줄기세포의 추출물을 0.5μg/mL의 농도로 사용하는 것을 바람직하다. For the composition for treating anti-inflammatory drugs induced by hydrogen peroxide of the amacrine stem cell extract of the present invention, it is preferable to use an adipose stem cell-derived adipose stem cell extract at a concentration of 0.5 μg/mL.

그리고, 상기 무막줄기세포는, 지방조직에서 지방줄기세포를 분리하여 정제한 후, 37℃에서, 5%의 CO2 조건의 인큐베이터(incubator)에서 초기배양 후, 계대배양을 6 내지 10회 반복하고, 배지를 제거한 후, 줄기세포의 세포막을 제거한 후 추출물을 획득하여 사용할 수 있다. And, after the adipose stem cells are separated and purified from the adipose tissue, the adipose stem cells are initially cultured in an incubator at 37 ° C. and 5% CO2 condition, and subculture is repeated 6 to 10 times, After removing the medium, after removing the cell membrane of the stem cells, the extract can be obtained and used.

이하, 본 발명인 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물의 항염증 실험에 대하여 상세하게 설명한다. Hereinafter, the anti-inflammatory experiment of the composition for the treatment of anti-inflammatory induced by hydrogen peroxide of the amacrine stem cell extract of the present invention will be described in detail.

1. 실험재료1. Experimental Materials

H2O2는 Junsei Chemical Co (Tokyo, Japan)에서 구입하였으며, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO)는 Sigma Chemical Co (St Louis,MO, USA)에서 구입하여 실험에 사용하였다. 단백질 추출 및 western blot analysis에서 사용된 RIPA buffer는 Elpis Biotech (Daejeon, Korea)에서, protease inhibitor cocktail은 Calbio Chem (Novabiochem, La Jolla, CA)에서, 1차 항체와 2차 항체는 Cell Signaling Technology (Beverly, MA, USA)와 Santa Cruz Biotechnology (Santa Cruz, MA, USA)에서 구입하여 사용하였다.H2O2 was purchased from Junsei Chemical Co (Tokyo, Japan), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO) was obtained from Sigma Chemical Co (St Louis). , MO, USA) and used in the experiment. The RIPA buffer used for protein extraction and western blot analysis was from Elpis Biotech (Daejeon, Korea), the protease inhibitor cocktail was from Calbio Chem (Novabiochem, La Jolla, CA), and the primary and secondary antibodies were Cell Signaling Technology (Beverly , MA, USA) and Santa Cruz Biotechnology (Santa Cruz, MA, USA) were purchased and used.

2. 무막줄기세포추출물 제조2. Manufacture of membraneless stem cell extract

본 시험에 사용된 무막줄기세포추출물은 ㈜티스템으로부터 제공받았다. 무막줄기세포추출물은 줄기세포 성분 추출물로, 인체지방조직에서 줄기세포를 분리, 배양한 후 세포막을 제거하여 획득하였다. 원재료인 지방조직은 혈액검사를 통해 이상이 없는 20대 여성 중 BMI 25 ~ 299에 해당하는 사람을 대상으로 지방공여동의서를 받고 확보하였다. 시행한 혈액검사 항목은 B형간염바이러스, C형간염바이러스, 인체면역결핍바이러스, 인체T림프영양성바이러스, 파보바이러스B19, 사이토메가로바이러스, 앱스타인바바이러스, 매독크레포네마 등이다. 최종제인 무막줄기세포는 Good Laboratory Practice 인정기관에서 안전성 검사를 완료하여 독성이 없는 물질임을 확인하였다. 위의 과정을 거쳐 획득한 지방조직에서 지방 줄기세포를 분리하여 정제한 후, 37℃, 5% CO2 조건의 incubator에서 초기배양을 실시하였으며, 세포가 자란 정도를 확인한 후 계대배양을 6~10회 반복하였다. 배지를 제거하고 줄기세포를 일정량 수득하여 초음파 등의 물리적 방법을 사용하여 세포막을 벗기고, 필터 등의 방법을 이용하여 세포막 조각을 제거하여 무막줄기세포추출물을 획득하였다. 수용액 상태의 무막줄기세포추출물은 동결건조하여 파우더 제형으로 만든 후 5 ± 2℃에서 보관하였다.The amucosal stem cell extract used in this test was provided by Tistem Co., Ltd. Membraneless stem cell extract is a stem cell component extract, obtained by separating and culturing stem cells from human adipose tissue and then removing the cell membrane. Adipose tissue, which is a raw material, was obtained by obtaining a consent form for local donation from women in their 20s who had no abnormalities through blood tests and had a BMI of 25 to 299. The blood tests performed were hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human T lymphotrophic virus, parvovirus B19, cytomegalovirus, Abstein-Barr virus, and syphilis creponema. The final product, amacrine stem cells, has been tested for safety by a Good Laboratory Practice accredited institution and confirmed that it is a non-toxic substance. After separating and purifying adipose stem cells from the adipose tissue obtained through the above process, initial culture was performed in an incubator at 37°C and 5% CO2 conditions. After checking the degree of cell growth, subculture was performed 6 to 10 times. repeated. After removing the medium and obtaining a certain amount of stem cells, the cell membrane was peeled off using a physical method such as ultrasound, and the cell membrane fragments were removed using a method such as a filter to obtain a membraneless stem cell extract. The aqueous membrane-free stem cell extract was lyophilized to form a powder formulation and stored at 5 ± 2°C.

3. 세포 종류 및 시약3. Cell Types and Reagents

본 실험에 사용한 human periodontal ligament fibroblasts (이하 HPLF) 세포는 ScienCell사(Carlsbad,CA, USA)에서 분양받아 실험에 사용하였다. 배양을 위해 fetal bovine serum (FBS), fibroblast growth supplement, penicillin/streptomycin solution, fibroblast medium 배지, trypsin-ethylenediaminetetraacetic acid (EDTA) 용액은 ScienCell사 (Carlsbad, CA, USA)에서 구입하여 사용하였다.Human periodontal ligament fibroblasts (hereafter, HPLF) cells used in this experiment were purchased from ScienCell (Carlsbad, CA, USA) and used in the experiment. For culture, fetal bovine serum (FBS), fibroblast growth supplement, penicillin/streptomycin solution, fibroblast medium medium, and trypsin-ethylenediaminetetraacetic acid (EDTA) solution were purchased from ScienCell (Carlsbad, CA, USA) and used.

4. 세포 배양4. Cell Culture

HPLF 세포는 2% FBS, 1% fibroblast growth supplement, 1% penicillin/streptomycin solution을 포함하는 fibroblast medium 배지를 사용하여 37℃, 5% CO2 incubator에서 배양하였다. 배양된 세포는 1~3일에 한 번씩 배양액을 교체하면서 배양하여 80-90% confluence 상태에서 phosphate buffered saline (PBS, pH 74)으로 세포를 세척한 후 025% trypsin EDTA 혼합액으로 부착된 세포를 분리하여 1,000 rpm에서 5분간 원심분리 한 후 현탁하여 계대 배양하면서 실험에 사용하였다.HPLF cells were cultured in a fibroblast medium containing 2% FBS, 1% fibroblast growth supplement, and 1% penicillin/streptomycin solution at 37°C and 5% CO2 incubator. Cultured cells are cultured while changing the culture medium once every 1 to 3 days, washed with phosphate buffered saline (PBS, pH 74) under 80-90% confluence, and then adhered cells are separated with 025% trypsin EDTA mixture. After centrifugation at 1,000 rpm for 5 minutes, the suspension was used for the experiment while subcultured.

5. 세포 생존율 측정5. Cell Viability Measurement

산화적 손상에 대한 세포 보호 효과를 확인하기 위해 세포 생존율을 MTT assay에 의해 측정하였다. HPLF 세포는 5×104 cells/mL로 96 well plate에 seeding 후 24시간 동안 37℃에서 배양하였다. 세포가 잘 부착되면 무막줄기세포추출물(0025, 005, 01,025, 05 μg/mL)을 각각의 농도로 처리하여 4시간 재배양한 후, H2O2 (100 μM)를 처리하여 24시간 배양한 뒤 5 mg/mL의 MTT solution을 각 well에 주입하였다.To determine the cytoprotective effect against oxidative damage, cell viability was measured by MTT assay. HPLF cells were seeded in 96 well plates at 5×104 cells/mL and incubated at 37° C. for 24 hours. When the cells are well adhered, the membrane-free stem cell extract (0025, 005, 01,025, 05 μg/mL) is treated at each concentration and cultured for 4 hours, then treated with H2O2 (100 μM) and incubated for 24 hours, followed by 5 mg /mL of MTT solution was injected into each well.

MTT solution을 처리한 후, 37℃에서 4시간 동안 재배양한 후 생성된 formazan 결정을 DMSO에 녹여 30분간 실온에서 방치 후, 540 nm에서 흡광도를 측정하였다. Control군의 경우 무막줄기세포추출물을 처리하지 않고, H2O2 (100 μM)만을 처리하여 실험을 진행하였다.After treatment with the MTT solution, the resulting formazan crystals were dissolved in DMSO after culture at 37° C. for 4 hours, left at room temperature for 30 minutes, and absorbance was measured at 540 nm. In the case of the control group, the experiment was carried out by treating only H2O2 (100 μM) without treatment with a membrane-free stem cell extract.

6 Western blot analysis6 Western blot analysis

염증 및 세포사멸 관련 단백질 발현 확인은 western blot analysis에 의해 측정하였다. 배양한 세포에 RIPA buffer를 첨가하여 4℃, 12,000 rpm에서 30분간 원심분리한 뒤, 상층액을 이용하여 단백질 정량을 실시하였다. 각각의 시료를 8-10% sodium dodecyl sulphate-polyacrlamide (SDS-PAGE) gel 에서 전기영동하여 membrane에 transfer하였다. 단백질이 부착된 membrane은 5% skim milk로 상온에서 50분간 blocking 한 다음, 1차 항체 [nuclear factor kappa light chain enhancer of activated B cells (NF-κB, 1:1000); inducible nitric oxide synthase (iNOS 1:1000); caspase-9 (1:1000); caspase-3 (1:1000);Poly (ADP-ribose) polymerase (PARP, 1:1000);interleukine-6 (IL-6, 1:200); B-cell lymphoma 2(Bcl-2)-associated X protein (Bax, 1:100); Bcl-2(1:200)]를 4℃에서 overnight 반응시킨 후, PBS-T로 세척하고 2차 항체 [Anti-rabbit and anti-mouse IgG HRP-linked antibody (1:1000)]와 상온에서 1시간 반응시켰다. 이후 enhanced chemiluminescence (ECL) solution과 반응시켜 Chemilium inescence image system (Davinch-ChemiTM)을 이용하여 단백질 발현을 확인하였다.Inflammation and apoptosis-related protein expression was determined by western blot analysis. After adding RIPA buffer to the cultured cells and centrifuging at 4°C and 12,000 rpm for 30 minutes, protein quantification was performed using the supernatant. Each sample was electrophoresed on 8-10% sodium dodecyl sulphate-polyacrlamide (SDS-PAGE) gel and transferred to the membrane. The protein-attached membrane was blocked with 5% skim milk at room temperature for 50 minutes, and then primary antibody [nuclear factor kappa light chain enhancer of activated B cells (NF-κB, 1:1000); inducible nitric oxide synthase (iNOS 1:1000); caspase-9 (1:1000); caspase-3 (1:1000); Poly (ADP-ribose) polymerase (PARP, 1:1000); interleukine-6 (IL-6, 1:200); B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax, 1:100); Bcl-2(1:200)] was reacted overnight at 4°C, washed with PBS-T, and mixed with a secondary antibody [Anti-rabbit and anti-mouse IgG HRP-linked antibody (1:1000)] at room temperature for 1 time was reacted. After reacting with an enhanced chemiluminescence (ECL) solution, protein expression was confirmed using a Chemilium inescence image system (Davinch-ChemiTM).

7. 통계분석7. Statistical analysis

모든 실험 결과는 Statistical Package for the Social Sciences (SPSS, Chicago, USA) 프로그램을 통해 analysis of variance (ANOVA) test를 하였으며, 시료간의 유의성 분석을 위해 Duncan’s multiple range test를 이용하여 P < 005 유의수준으로 분석하였다.All experimental results were analyzed by analysis of variance (ANOVA) through the Statistical Package for the Social Sciences (SPSS, Chicago, USA) program. did.

8. 무막줄기세포추출물의 H2O2로 인한 손상으로부터 세포 생존에 미치는 효과8. Effect of membraneless stem cell extract on cell survival from H2O2 damage

HPLF 세포에 각 무막줄기세포추출물을 농도별로 처리하고(0025 - 1 μg/mL) 24시간 배양한 뒤, MTT assay를 이용하여 무막줄기세포추출물의 세포 독성 여부After each concentration of non-membranous stem cell extracts were treated on HPLF cells (0025 - 1 μg/mL) and cultured for 24 hours, MTT assay was used to determine the cytotoxicity of the non-membrane stem cell extracts.

를 검토하였다. 그 결과, 표 1에 나타난 바와 같이, 무막줄기세포추출물 05μg/mL까지 95% 이상의 세포 생존율을 보여 세포 독성이 없는 것으로 나타났다.was reviewed. As a result, as shown in Table 1, up to 05 μg/mL of the membraneless stem cell extract showed a cell viability of more than 95%, indicating that there was no cytotoxicity.

Treatment(μg/ml)Treatment (μg/ml) Cell viability(%)Cell viability (%) 00 100.00±1.07100.00±1.07 0.0250.025 100.53±2.99100.53±2.99 0.050.05 93.02±1.4693.02±1.46 0.10.1 91.79±1.5991.79±1.59 0.250.25 90.85±2.3290.85±2.32 0.50.5 95.41±1.5495.41±1.54

무막줄기세포추출물의 H2O2로 인한 산화적 손상에 대한 세포 보호 효과를 확인하기 위해, HPLF 세포에 100 μM H2O2를 처리하여 산화적 손상을 유도한 뒤, 세포 독성이 없는 범위 내의 농도별 무막줄기세포추출물을 처리하여 세포 생존율을 측정하였다. 도 1에 도시된 바와 같이, HPLF 세포에 H2O2를 단독으로 처리한 control군의 경우 normal군 100% 대비 6150%의 세포 생존율을 보여 H2O2의 처리로 인한 세포 손상을 확인하였다. In order to confirm the cytoprotective effect of the membraneless stem cell extract against oxidative damage caused by H2O2, oxidative damage was induced by treating HPLF cells with 100 μM H2O2, and then the membraneless stem cell extract by concentration within the range of no cytotoxicity. was treated to measure cell viability. As shown in FIG. 1 , in the case of the control group treated with H2O2 alone in the HPLF cells, the cell viability was 6150% compared to 100% of the normal group, confirming the cell damage caused by the H2O2 treatment.

반면 무막줄기세포추출물을 처리한 군의 경우, control군에 비해 세포생존율이 증가하는 것을 확인하였으며, 이는 지방조직 유래 무막줄기세포추출물이 H2O2로 인한 세포 손상에 대해 보호 효과를 갖는 것으로 사료된다.On the other hand, it was confirmed that the cell viability increased in the group treated with amacrine stem cell extract compared to the control group, which is considered to have a protective effect against cell damage caused by H2O2.

9. 무막줄기세포추출물의 염증 개선 효과9. Inflammation improvement effect of amucosal stem cell extract

염증 반응은 감염이나 자극에 대한 체내 면역체계의 초기 반응 중 하나로, H2O2로 인한 산화적 손상은 NF-κB pathway를 활성화시켜 염증 반응을 일으킨다. NF-κB는 p50와 p65의 두 가지 subunits으로 구성되어 heterodimer 구조를 형성하고 있으며, inhibition of nuclear transcription factor-κB (IκB)와 결합하여 비활성화 형태로 존재한다. 산화적 손상 등의 외부 자극에 의해 활성화 될 경우 IkB가 분리되어 NF-κB의 subunits이 핵 내로 이동하면서, 염증 관련 매개체 및 cytokine 등의 유전자 전사를 유도한다. 이렇게 과발현된 염증 매개체 및 cytokine 등은 유전자 변이 및 세포 손상을 유도한다.The inflammatory response is one of the initial responses of the body's immune system to infection or stimuli, and oxidative damage caused by H2O2 activates the NF-κB pathway to cause an inflammatory response. NF-κB is composed of two subunits, p50 and p65, to form a heterodimer structure, and exists in an inactivated form by binding with inhibition of nuclear transcription factor-κB (IκB). When activated by external stimuli such as oxidative damage, IkB is dissociated and NF-κB subunits move into the nucleus, inducing the transcription of genes such as inflammation-related mediators and cytokines. Such overexpressed inflammatory mediators and cytokines induce genetic mutations and cell damage.

H2O2를 처리한 HPLF 세포는 치주 염증에 대한 in vitro 모델로 널리 사용되고 있다. 따라서 본 연구에서 HPLF 세포에서 무막줄기세포추출물의 H2O2에 대한 염증 보호 기전을 확인하기 위해, 도 2에서 염증 관련 인자인 NF-κB, iNOS 및 IL-6 단백질 발현을 측정하였다. 아무것도 처리하지 않은 normal군에 비해 H2O2 만을 처리한 control군에서 염증 관련 단백질의 발현이 유의적으로 증가하여 H2O2에 의해 염증 반응이 유도되었음을 알 수 있었다. 반면 무막줄기세포추출물을 처리하였을 때 control군에 비해 이들 단백질의 발현이 억제됨을 확인하였다. 특히 무막줄기세포추출물 05 μg/mL의 농도에서 가장 낮은 발현을 보이는 것을 확인하였다. 이는 무막줄기세포추출물이 H2O2에 의해 활성화된 NF-κB pathway 조절을 통해 염증 매개체 및 염증성 cytokine을 조절하여 염증 반응 보호 효과를 나타낸 것을 사료된다. HPLF cells treated with H2O2 are widely used as an in vitro model for periodontal inflammation. Therefore, in this study, in order to confirm the inflammatory protective mechanism against H2O2 of the amacrine stem cell extract in HPLF cells, the expression of NF-κB, iNOS and IL-6 proteins, which are inflammation-related factors, was measured in FIG. 2 . In the control group treated with only H2O2, the expression of inflammation-related proteins was significantly increased compared to the normal group untreated, and it was found that the inflammatory response was induced by H2O2. On the other hand, it was confirmed that the expression of these proteins was suppressed when compared to the control group when the membraneless stem cell extract was treated. In particular, it was confirmed that the lowest expression was observed at a concentration of 05 μg/mL of the amenorrhea stem cell extract. It is thought that the amacrine stem cell extract showed an inflammatory response protective effect by regulating inflammatory mediators and inflammatory cytokines through the regulation of the NF-κB pathway activated by H2O2.

국내·외 연구에 의하면, 지방조직 유래 줄기세포는 pro-inflammation factor 억제 및 NF-κB pathway 활성화 조절과 nitric oxide 생성을 저해함으로써 항염증 효과가 있는 것으로 보고되었다. 또한, 지방조직유래 무막줄기세포추출물은 골프로 인한 관절, 인대, 힘줄 및 근육에 염증을 동반한 통증을 항염증 및 재생기능에 의해 개선시켰으며, 산화적 손상으로 인한 피부세포의 염증반응 또한 개선시켰다. 따라서 지방조직유래 무막줄기세포추출물은 산화적 손상으로 인한 염증반응에 대한 보호 효과가 있는 것으로 사료된다.According to domestic and foreign studies, adipose tissue-derived stem cells have been reported to have anti-inflammatory effects by inhibiting pro-inflammation factor, regulating NF-κB pathway activation, and inhibiting nitric oxide production. In addition, adipose tissue-derived amucosal stem cell extract improved the pain accompanying inflammation in the joints, ligaments, tendons and muscles caused by golf by anti-inflammatory and regenerative functions, and also improved the inflammatory response of skin cells due to oxidative damage. did it Therefore, it is considered that the adipose tissue-derived amucosal stem cell extract has a protective effect against the inflammatory reaction caused by oxidative damage.

10. 무막줄기세포추출물의 세포사멸 보호 기전10. Mechanism of protection against apoptosis of a membrane-free stem cell extract

세포 내 과량의 H2O2로 인한 산화적 손상은 미토콘드리아 막전위를 감소시켜 미토콘드리아 기능 장애에 의해 DNA 및 단백질의 분해와 세포 사멸을 매개하는 caspase를 활성화시킨다. 산화적 손상 시 미토콘드리아는 cytochrome-c를 방출시키고, 이는 caspase-9, caspase-3, PARP의 활성화를 통해 세포 핵 응축을 유도시켜 세포사멸을 일으킨다. 본 연구에서 도 3에 도시된 바와 같이, H2O2로 산화적 손상을 유도한 HPLF 세포에서 지방유래 무막줄기세포추출물의 세포사멸 보호 작용 기전을 확인하기 위해, caspase-9, -3, PARP 단백질 발현을 측정하였다. 아무것도 처리하지 않은 정상군과 비교하여 H2O2를 처리한 control군은 유의적으로 cleaved caspase-9/caspase-9, cleaved caspase-3/caspase-3, cleaved PARP/PARP의 단백질 발현 비율이 증가하여 caspase 활성화를 통한 세포사멸이 유발됨을 확인하였다. 반면 무막줄기세포추출물을 처리한 군의 경우 control군에 비해 cleaved caspase-9, -3, PARP 단백질 발현이 감소함을 확인하였다. 또한, 이전 연구에 의하면, 지방조직 유래 줄기세포는 cisplatin으로 세포사멸이 유도된 혀 편평세포에서 caspase-9, -3 활성화 조절을 통해 세포사멸 보호 효과를 나타내었다. 따라서 지방조직 유래 무막줄기세포추출물은 caspase 활성화 감소를 통해 산화적 손상에 대한 세포사멸 보호 효과가 있는 것으로 생각된다.Oxidative damage caused by excessive intracellular H2O2 reduces the mitochondrial membrane potential and activates caspase that mediates cell death and DNA and protein degradation by mitochondrial dysfunction. Upon oxidative damage, mitochondria release cytochrome-c, which induces cell nuclear condensation through activation of caspase-9, caspase-3, and PARP, leading to apoptosis. As shown in FIG. 3 in this study, in order to confirm the apoptosis protective mechanism of the adipose-derived amacrine stem cell extract in HPLF cells induced with oxidative damage with H2O2, the expression of caspase-9, -3, and PARP proteins was measured. Compared with the normal group untreated, the control group treated with H2O2 significantly increased the protein expression ratio of cleaved caspase-9/caspase-9, cleaved caspase-3/caspase-3, and cleaved PARP/PARP to activate caspase It was confirmed that apoptosis was induced through On the other hand, it was confirmed that the expression of cleaved caspase-9, -3, and PARP proteins was decreased in the group treated with the membrane-free stem cell extract compared to the control group. In addition, according to a previous study, adipose tissue-derived stem cells exhibited apoptosis protective effect by regulating caspase-9 and -3 activation in cisplatin-induced apoptosis-induced tongue squamous cells. Therefore, it is thought that adipose tissue-derived acellular stem cell extracts have apoptotic protective effect against oxidative damage through reduced caspase activation.

Bcl family는 세포사멸에 관여하는 대표적인 작용 기전 중 하나로써, pro-apoptotic 인자인 Bax의 과발현은 cytochrome-c의 생성을 증가시켜 세포사멸을 유도하며, anti-apoptotic 인자인 Bcl-2는 cytochrome-c생성을 감소시켜 세포사멸을 보호하는 역할을 하는 것으로 알려져 있다. Bax/Bcl-2 비율의 단백질 발현 측정을 통해 세포사멸 보호 효과를 측정한 결과, 정상군에 비해 control군에서 유의적인 단백질 발현 증가를 확인하였다. 반면 무막줄기세포추출물을 처리하였을 때 01,05 μg/mL 농도에서 control군에 비해 유의적으로 세포사멸과 관련된 단백질 발현을 하향 조절함으로써 지방유래 무막줄기세포추출물은 Bax와 Bcl-2 단백질 발현 비율 조절을 통해 세포사멸 보호 효과가 있는 것으로 사료된다. Chiu 등은 지방조직 유래 줄기세포는 세포사멸이 유도된 혀 편평세포의 pro-apoptotic 인자인 Bad 단백질 억제를 통해 세포사멸 억제 효능을 보고하였으며, 이 외에도 다양한 조직에서의 세포사멸 보호를 통한 조직 재생성 효능이 보고되었다. 또한, 지방조직유래 줄기세포 추출물은 amyloid beta로 유도된 신경세포 사멸에 대해 p53/Foxo pathway 조절을 통한 세포보호 효과가 확인되었다. 따라서 지방조직 유래 줄기 세포 추출물은 caspase 활성화, Bcl family 조절 등 다양한 pathway 조절을 통해 세포 사멸 보호 효과를 나타내는 것으로 사료된다.The Bcl family is one of the representative mechanisms involved in apoptosis. Overexpression of the pro-apoptotic factor, Bax, induces apoptosis by increasing the production of cytochrome-c, and the anti-apoptotic factor, Bcl-2, induces apoptosis. It is known to play a role in protecting apoptosis by reducing production. As a result of measuring the apoptosis protective effect by measuring the protein expression of the Bax/Bcl-2 ratio, a significant increase in protein expression was confirmed in the control group compared to the normal group. On the other hand, when the membrane-free stem cell extract was treated, the adipose-derived membrane-free stem cell extract significantly down-regulated the expression of apoptosis-related protein compared to the control group at a concentration of 01,05 μg/mL, thereby regulating the expression ratio of Bax and Bcl-2 proteins. It is thought to have an apoptosis protective effect through Chiu et al. reported that adipose tissue-derived stem cells were effective in inhibiting apoptosis through inhibition of Bad protein, a pro-apoptotic factor in apoptosis-induced tongue squamous cells. This has been reported In addition, the adipose tissue-derived stem cell extract was confirmed to have a cytoprotective effect through the regulation of the p53/Foxo pathway against amyloid beta-induced apoptosis. Therefore, it is thought that the adipose tissue-derived stem cell extract exhibits apoptotic protective effect through various pathways such as caspase activation and Bcl family regulation.

이와 같이, 상술한 본 발명의 기술적 구성은 본 발명이 속하는 기술분야의 당업자가 본 발명의 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다.As such, those skilled in the art to which the present invention pertains will understand that the above-described technical configuration of the present invention may be implemented in other specific forms without changing the technical spirit or essential characteristics of the present invention.

그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적인 것이 아닌 것으로서 이해되어야 하고, 본 발명의 범위는 상기 상세한 설명보다는 후술하는 청구범위에 의하여 나타나며, 청구범위의 의미 및 범위 그리고 그 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.Therefore, the embodiments described above are to be understood as illustrative and not restrictive in all respects, and the scope of the present invention is indicated by the following claims rather than the above detailed description, and the meaning and scope of the claims and their equivalents It should be construed as being included in the scope of the present invention all changes or modifications derived from it.

Claims (2)

지방줄기세포에서 유래된 무막줄기세포의 추출물을 0.5μg/mL의 농도로 사용하는 것을 특징으로 하는 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물.A composition for the treatment of anti-inflammatory treatment induced by hydrogen peroxide of a membrane-free stem cell extract, characterized in that the extract of the adipose stem cell-derived adipose stem cell is used at a concentration of 0.5 μg/mL. 제 1항에 있어서,
상기 무막줄기세포는,
지방조직에서 지방줄기세포를 분리하여 정제한 후, 37℃에서, 5%의 CO2 조건의 인큐베이터(incubator)에서 초기배양 후, 계대배양을 6 내지 10회 반복하고, 배지를 제거한 후, 줄기세포의 세포막을 제거한 후 추출물을 획득하는 것을 특징으로 하는 무막줄기세포추출물의 과산화수소에 의해 유도된 항염증 치료용 조성물.
The method of claim 1,
The amacrine stem cells are
After separating and purifying adipose stem cells from adipose tissue, after initial culture at 37° C. in an incubator under 5% CO2 conditions, subculture is repeated 6 to 10 times, and after removing the medium, the stem cells A composition for treating anti-inflammatory treatment induced by hydrogen peroxide of a membrane-free stem cell extract, characterized in that the extract is obtained after removing the cell membrane.
KR1020200032929A 2020-03-18 2020-03-18 A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell KR102419735B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200032929A KR102419735B1 (en) 2020-03-18 2020-03-18 A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200032929A KR102419735B1 (en) 2020-03-18 2020-03-18 A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell

Publications (2)

Publication Number Publication Date
KR20210116851A true KR20210116851A (en) 2021-09-28
KR102419735B1 KR102419735B1 (en) 2022-07-12

Family

ID=77923134

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200032929A KR102419735B1 (en) 2020-03-18 2020-03-18 A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell

Country Status (1)

Country Link
KR (1) KR102419735B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023106691A1 (en) * 2021-12-09 2023-06-15 주식회사 티스템 Composition for prevention or treatment of animal skin disease using membrane-free stem cell extract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102082745B1 (en) 2018-05-08 2020-02-28 주식회사 휴코드 A method for preparing a stem cell secreting anti-inflammatory substances and anti-inflammatory compositions comprising culture medium of the stem cell

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102082745B1 (en) 2018-05-08 2020-02-28 주식회사 휴코드 A method for preparing a stem cell secreting anti-inflammatory substances and anti-inflammatory compositions comprising culture medium of the stem cell

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Venu Venkatarame Gowda Saralamma et al. Cell Components by Nano-LS/MS Analysis and Its Anti-Inflammatory Activity. Evidence-Based Complementary and Alternative Medicine, V.2019, pp.1-12 (2019.11.04.)* *
허메이통 et al. 무막줄기세포추출물의 H2O2에 의해 유도된 치주 세포의 염증 반응 보호 효과. Journal of the Korea Academia-Industrial cooperation Society, Vol.20(6), pp.95-103 (2019.06.30.)* *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023106691A1 (en) * 2021-12-09 2023-06-15 주식회사 티스템 Composition for prevention or treatment of animal skin disease using membrane-free stem cell extract

Also Published As

Publication number Publication date
KR102419735B1 (en) 2022-07-12

Similar Documents

Publication Publication Date Title
Li et al. Exosomes secreted by stem cells from human exfoliated deciduous teeth contribute to functional recovery after traumatic brain injury by shifting microglia M1/M2 polarization in rats
Trubiani et al. Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis
EP2311474A2 (en) Antioxidant, anti-inflammatory, or anti-aging composition containing a plant stem cell line derived from taxus cambium or procambium as an active ingredient
Han et al. Effect of honey bee venom on microglial cells nitric oxide and tumor necrosis factor-α production stimulated by LPS
Lee et al. Ginsenosides from Korean red ginseng inhibit matrix metalloproteinase-13 expression in articular chondrocytes and prevent cartilage degradation
Kim et al. Protective effect of ginsenoside Rb1 on hydrogen peroxide-induced oxidative stress in rat articular chondrocytes
Al-Hanbali et al. Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-κB nuclear translocation in whole blood stimulated system
Aslam et al. Umbilical cord-derived mesenchymal stem cells preconditioned with isorhamnetin: potential therapy for burn wounds
EP2305829A2 (en) Method for screening for skin wrinkling- and sagging-improving agents using skin cells
Zhang et al. Protective effects of the king oyster culinary-medicinal mushroom, Pleurotus eryngii (Agaricomycetes), polysaccharides on β-amyloid-induced neurotoxicity in PC12 cells and aging rats, in vitro and in vivo studies
Calabrese et al. Hormesis and neural stem cells
Yamane et al. Reduction of blood pressure by aronia berries through inhibition of angiotensin-converting enzyme activity in the spontaneously hypertensive rat kidney
CN116103231A (en) Preconditioning mesenchymal stem cells, preparation and application thereof
KR102419735B1 (en) A Abti-Inflammation Material H2O2-Induced from Membrane-Free Stem Cell
Costantini et al. Neuroprotective potential of Bacopa monnieri: Modulation of inflammatory signals
Chen et al. Ginkgolide A improves the pleiotropic function and reinforces the neuroprotective effects by mesenchymal stem cell-derived exosomes in 6-OHDA-induced cell model of Parkinson’s disease
Hu et al. Rg1 protects rat bone marrow stem cells against hydrogen peroxide-induced cell apoptosis through the PI3K/Akt pathway
Han et al. Corosolic acid protects rat chondrocytes against IL-1β-induced ECM degradation by activating autophagy via PI3K/AKT/mTOR pathway and ameliorates rat osteoarthritis
Anari et al. In Vitro Effect of Methamphetamine on Proliferation, Differentiation and Apoptosis of Adipose Tissue Stem Cells: In vitro Effect of Methamphetamine
KR20220028557A (en) Composition of membrane free stem cell for improvng oxidative stress
Yang et al. Smilagenin induces expression and epigenetic remodeling of BDNF in alzheimer's disease
Jinghua et al. Amelioration of oxidative stress through apoptosis-mediated pathway in colon cancer cells by hexane fraction of Moringa oleifera extract
Dalirfardouei et al. Osteogenic induction of menstrual blood mesenchymal stem cell by different Ferula species extracts
Zheng et al. The Effect of an Extract of Sappanwood, Protosappanin A and Protosappanin B on Osteogenesis in Periodontitis
CN115919816B (en) Application of curcumin-tetrahedron framework nucleic acid drug carrier system in preparation of drugs for preventing or treating radioactive oral mucositis

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant